Listen to a panel of leading experts discuss how biomarker-driven insights and emerging therapies are shaping treatment decisions in PDAC. They cover early testing strategies, novel targeted and immunologic therapies, and evidence-based treatment sequencing across the disease continuum.
The experts:
Dr. Allyson Ocean - Weill Cornell Medicine, New York, NY, USA
Prof. Thierry Conroy - Institut de Cancérologie de Lorraine, University of Lorraine Nancy, France
Dr. Eileen O'Reilly - Memorial Sloan Kettering Cancer Center, New York NY, United States
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Revolution Medicines.
The activity is jointly provided by USF Health and touchIME.
Podden och tillhörande omslagsbild på den här sidan tillhör
touchpodcast. Innehållet i podden är skapat av touchpodcast och inte av,
eller tillsammans med, Poddtoppen.
